The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996

BJU International

Volumn 84, Issue 1, 1999, Pages 68-74

  Sonneveld, D J A ^a   Hoekstra, H J ^a   Van Der Graaf, W T A ^a   Sluiter, W J ^a   Koops, H Schraffordt ^a   Sleijfer, D Th ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Delay in diagnosis; Nonseminoma; Patient education; Prognostic factor; Stage distribution; Testicular cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TESTIS CANCER; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; GERMINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 0032785636     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00072.x     Document Type: Article

References (28)

1. 1 Buetow S. Epidemiology of testicular cancer. Epidemiol Rev 1995: 17: 433-49
2. 2 Bosl GJ, Vogelzang NJ, Goldman A et al. Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet 1981; 2: 970-3
3. 3 Medical Research Council Working Party. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Lancet 1985; 2: 8-11
4. 4 Jones WG, Appleyard I. Delay in diagnosing testicular tumours. Br Med J 1985; 290: 1550
5. 5 Thornhill JA, Fennelly JJ, Kelly DG, Walsh A, Fitzpatrick JM. Patients' delay in the presentation of testis cancer in Ireland. Br J Urol 1987; 59: 447-51
6. 6 Chilvers CED, Saunders M, Bliss JM, Nicholls J, Horwich A. Influence of delay in diagnosis on prognosis in testicular teratoma. Br J Cancer 1989; 59: 126-8
7. 7 Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. J Urol 1990; 143: 520-3
8. 8 Stoter G, Sleijfer DTh, Vendrik CPJ et al. Combination chemotherapy with cis-diamminedichloroplatinum, vinblastine and bleomycin in advanced testicular non-seminoma. Lancet 1979; 1: 941-5
9. 9 Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990; 8: 1777-81
10. 10 Peckham MJ, Horwich A, Easton DF, Hendry WF. The management of advanced testicular teratoma. Br J Urol 1988; 62: 63-8
11. 11 Birch R, Williams S, Cone A et al. Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 1986; 4: 400-7
12. 12 Stoter G, Sylvester R, Sleijfer DTh et al. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer multi-institutional Phase III study. Cancer Res 1987; 47: 2714-8
13. 13 International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancer. J Clin Oncol 1997; 15: 594-603
14. 14 Moul JW, Heidenreich A. Prognostic factors in low-stage nonseminomatous testicular cancer. Oncology 1996; 10: 1359-68
15. 15 Hitchins RN, Newlands ES, Smith DB, Begent RHJ, Rustin GJS, Bagshawe KD. Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis. Br J Cancer 1989; 59: 236-42
16. 16 Bajorin D, Katz A, Chan E, Geller N, Vogelzang N, Bosl GJ. Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies. J Clin Oncol 1988; 6: 786-92
17. 17 Heimdal K, Fossa SD, Johansen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-87. Br J Cancer 1990; 62: 277-8
18. 18 Hernes EH, Harstad K, Fossa SD. Changing incidence and delay of testicular cancer in Southern Norway (1981-92). Eur Urol 1996; 30: 349-57
19. 19 Horwich A, Huddart R, Dearnaley D. Markers and management of germ-cell tumours of the testes. Lancet 1998; 352: 1535-8
20. 20 Peckham MJ, Barret A, McElwain TJ, Hendry WF. Combined management of malignant teratoma of the testis. Lancet 1979; 2: 267-70
21. 21 Krag Jacobsen G, Barlebo H, Olsen J et al. Testicular germ cell tumours in Denmark 1976-80. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984; 23: 239-47
22. 22 Mead GM, Stenning SP, Parkinson MC et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumours. J Clin Oncol 1992; 10: 85-94
23. 23 Fossa SD, Klepp O, Elgjo RF et al. The effect of patient's delay and doctor's delay in patients with malignant germ cell tumours. Int J Androl 1981; 4 (Suppl): 134-45
24. 24 Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New Engl J Med 1985; 312: 1604-8
25. 25 Bosl GJ, Geller NL, Chan EYW. Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors. Cancer Res 1988; 48: 3524-7
26. 26 Wishnow KI, Johnson DE, Preston WL, Tenney DM, Brown BW. Prompt orchidectomy reduces morbidity and mortality from testicular carcinoma. Br J Urol 1990; 65: 629-33
27. 27 Bosl GJ, Motzer RJ. Testicular germ-cell cancer, New Engl J Med 1997; 337: 242-53
28. 28 Van Basten JPA, Jonker-Pool G, Van Driel MF et al. The sexual sequelae of testicular cancer. Cancer Treat Rev 1995; 21: 479-95